Mercapital makes €100m on Gasmedi sale
Mercapital has sold Spanish respiratory home therapies firm Gasmedi to French gas company Air Liquide for €330m.
The exit saw Mercapital reap a 2.4x multiple and capital gains of more than €100m.
Air Liquide supplies gases to the industrial, health and environmental sectors and is present in 80 countries. The acquisition will strengthen the group's presence in international markets.
Previous funding
In 2006, Mercapital acquired a 70% stake in the company for €76m.
Company
Founded in 1996 and based in Madrid, Gasmedi provides respiratory home therapies and medical gases to hospitals.
The firm currently serves 125,000 patients and reports an annual turnover of €82m, twice the figure reported at the time of the original acquisition in 2006. Mercapital grew the firm by extending its range of products and services and focusing on international expansion.
People
Javier Loizaga is CEO of Mercapital.
Advisers
Vendor – Goldman Sachs (Corporate finance).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








